A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 495.63
C 34.06
GOOG 610.58
BAC 8.22
RIMM 16.17

Recently Added

CPIC 1.23
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.80

Gaining Speed

COHO 0.00
NBTH 12.50
SHMX 0.00
CPIC 1.23
AVEW 0.00
0.90 +0.06 (6.52%) BPAX

Click Here to Receive Instant E-mail and RSS Alerts


Trade BPAX now with

Stock Details

Last Trade:0.90 Change:+0.06 (6.52%) Prev Close:0.84 Open: 0.92 Days Range:0.87 – 0.97 52 Week Range: 0.38 - 4.02 Volume:8628105 P/E: N/A
EPS:-0.67

Member Comments

No member comments available for BPAX


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 02/09/12 at 7:56am
BioSante (BPAX) Reports Positive Review from Independent DMC for LibiGel Phase III

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), reports that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed... Read More

Recent Alert on 02/09/12 at 7:56am
BioSante (BPAX) Reports Positive Review from Independent DMC for LibiGel Phase III
Recent Alert on 02/08/12 at 8:29am
BioSante (BPAX) Enters Agreement to Cancel $5M of Debt, Will Issue 6.7M Common in Deal
Recent Alert on 02/08/12 at 8:29am
BioSante (BPAX) Enters Agreement to Cancel $5M of Debt, Will Issue 6.7M Common in Deal
Recent Alert on 02/07/12 at 2:14pm
Unusual 11 Midday Movers 02/07: (SATC) (MNI) (CSTR) (SPF) Higher; (NSU) (CBM) (ASTX) Lower

View AllRecent Press Releases

Press Release on 02/09/12 at 7:55am
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review for Phase III Program
Press Release on 02/08/12 at 11:15am
BioSante Exchanges $5 Million Aggregate Principal Amount of Convertible Senior Notes for 6.7 Million Shares of Common Stock
Press Release on 02/07/12 at 9:00am
Perception, Opportunity in Volatility - Research & Analysis on Dendreon Corporation and BioSante Pharmaceuticals, Inc.

View AllRecent SEC Filings

SEC Filing on 02/09/12 at 10:00am
Form SC 13G BIOSANTE PHARMACEUTICALS Filed by: BlackRock Inc.
SEC Filing on 02/08/12 at 6:16am
Form 8-K BIOSANTE PHARMACEUTICALS For: Feb 07

View AllRecent Blog Posts

Blog Posts on 02/08/12 at 4:28pm
VIX - Options Volatility Sonar: Wednesday Recap
Blog Posts on 02/08/12 at 4:49am
3 Biotech Companies Down But Not Out
Blog Posts on 02/07/12 at 3:10pm
Big, Robust Pipelines At Small Biotech Companies
Blog Posts on 02/07/12 at 8:41am
Short Term Swing Trades 2 Week Report Card, With Deeper Analysis
Blog Posts on 02/06/12 at 11:33am
BioSante Has Potential To Double Soon